Sanofi says back on track to regain solid position in cancer drugs

Sanofi says back on track to regain solid position in cancer drugs

FILE PHOTO: A logo is seen in front of the entrance at the headquarters of French drugmaker Sanofi
A logo is seen in front of the entrance at the headquarters French drugmaker Sanofi in Paris Oct 30, 2014. (Photo: Reuters/Christian Hartmann)

PARIS: Sanofi believes it can make a comeback and re-establish a leading position in the competitive cancer drug market in the coming years on the back of its immunotherapy drugs and efforts in new areas such as molecular oncology.

"We missed the immunology wagon in recent years but we are committed to catching up and we have a significant number of assets," Jorge Insuasty, Sanofi's global head of development, told journalists on Wednesday (Jun 13).

Cancer immunotherapy has become the fastest-growing part of the US$100 billion-a-year cancer drug market, with sales expected to top US$25 billion by 2021, according to analyst forecasts compiled by Thomson Reuters.

Source: Reuters/zl

Bookmark